Drug Shortage Report for FORTAZ

Last updated on 2020-12-22 History
Report ID 4301
Drug Identification Number 02212234
Brand name FORTAZ - INJ 6G/VIAL
Common or Proper name Ceftazidime for injection
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CEFTAZIDIME
Strength(s) 6G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 6's
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-07-20
Estimated end date
Actual end date 2020-12-21
Shortage status Resolved
Updated date 2020-12-22
Company comments This product has been discontinued.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2020-12-22 French Compare
v25 2020-12-22 English Compare
v24 2020-02-27 French Compare
v23 2020-02-27 English Compare
v22 2019-10-18 French Compare
v21 2019-10-18 English Compare
v20 2019-07-10 French Compare
v19 2019-07-10 English Compare
v18 2019-04-10 French Compare
v17 2019-04-10 English Compare
v16 2018-12-03 French Compare
v15 2018-12-03 English Compare
v14 2018-05-30 French Compare
v13 2018-05-30 English Compare
v12 2018-04-04 French Compare
v11 2018-04-04 English Compare
v10 2017-07-21 French Compare
v9 2017-07-21 English Compare
v8 2017-07-21 English Compare
v7 2017-07-19 French Compare

Showing 1 to 20 of 26